# Ascenta Therapeutics, Inc.: Form D filing

Ascenta Therapeutics, Inc., a pharmaceuticals company in Malvern, PA, filed a Form D with the SEC in 2010. The latest, on February 5, 2010, reports $1.8 million sold of a $15 million offering to 12 investors.

Find out what Ascenta Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Ascenta%20Therapeutics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Ascenta%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fascenta-therapeutics-inc-1483471)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Ascenta%20Therapeutics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Ascenta%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fascenta-therapeutics-inc-1483471)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania): 987 rows, by operating companies, filed since November 1, 2024, $49.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/pennsylvania
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 101 LINDENWOOD DRIVE, SUITE 405, Malvern, PA, 19355
- Phone: (610) 408-0301
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1483471

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 5, 2010 | New notice | $15,001,500 | $1,800,180 | $13,201,320 | 12 | Jan 25, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1483471/000148347110000001/0001483471-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Joel Sussman | Executive Officer, Director |  |
| Eckard E. Weber | Director |  |
| Norman Selby | Director |  |
| Michael Powell | Executive Officer, Director |  |
| Louis Bock | Director |  |
| J. Mel Sorensen | Executive Officer, Director |  |
| Andrew E. Senyei | Director |  |
| Marc Lippman | Director |  |

## Other pharmaceuticals companies in Pennsylvania that filed recently

- [Telemachus Therapeutics, Inc.](https://specstream.ai/data/form-d/company/telemachus-therapeutics-inc-2152986) $375,000 · Oct 28, 2026
- [EpiVario Inc.](https://specstream.ai/data/form-d/company/epivario-inc-1753351) $185,000 · Oct 13, 2026
- [Maxona Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/maxona-pharmaceuticals-inc-1857448) $5.8 million · Aug 14, 2026

[Every Form D from the week of Feb 1, 2010](https://specstream.ai/data/form-d/week/2010-02-01) · [All recent filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Ascenta Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).